logo logo
  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
    • Vetted Prospectus
    • IPO Information
    • IPO Utilization Report
    • IPO Related Published News
  • PRODUCTS
    • Tablet
  • ANNUAL REPORTS
    • Annual Report
  • INVESTOR RELATIONS
    • Unclaimed / Unsettled Dividend
    • CG Compliance Status
    • Board of Directors
    • Director's Report
    • Quarterly Report
    • Audited Financial Statements
    • Dividend Distribution Policy
    • Code of Conduct
    • Annual General Meeting
    • PRICE SENSITIVE INFORMATION (PSI)
    • Code of Conduct
    • Corporate Brief
  • MEDIA
  • CAREER
  • WEBMAIL
  • LOGIN

Investor Relations

    Directors' Report for the year ended 30 June, 2022. Corporate Governance Compliance Report for the year ended 30 June, 2023 Proxy Form for 9th Annual General Meeting 2023 Notice of the 9th Annual General Meeting 2023 Auditors Report & Financial Statements for the year ended 30 June, 2023 1st Quarter (Q1) Financial Statements (2023-2024) PSI on First Quarter (Q1) Financial Statements (2023-2024) PSI regarding Record Date, AGM for the 2023 Third Quarter (Q-3) Financial Statements (2022-2023) PSI on Third Quarter (Q3) Financial Statements (2022-2023)
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 12
  • 13
  • ›
04312174811
04312174977
info@indo-banglapharma.com
Fax: +88-02-57164716 (Ext-101)

VISITOR COUNTER

2 2 6 2 0 7

Quick Links

  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
  • PRODUCTS
  • ANNUAL REPORTS

Quick Links

    • INVESTOR RELATIONS
    • MEDIA
    • CAREER
    • WEBMAIL
    • LOGIN

Copyright © 2025 Indo-Bangla Pharmaceuticals Limited

Develop By : Motaharul Islam